UK firms move from AI experimentation to measurable results as the Project Economy matures
Nearly half of UK organisations report productivity or cost improvements from AI,…
Xinhua Silk Road: Ningbo and China’s shift from making things to making them smarter
BEIJING, April 17, 2026 /PRNewswire/ -- Along China's eastern seaboard, the Ningbo-Zhoushan Port…
Sigenergy Successfully Listed on HKEX with Strong Backing from Top-Tier Global Investors
HONG KONG, April 16, 2026 /PRNewswire/ -- Sigenergy Technology Co., Ltd. ("Sigenergy",…
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS…
Risen Energy Secures 1.2GW HJT Module Order from China Huaneng Group, Demonstrating Industry Leadership
NINGBO, China, April 15, 2026 /PRNewswire/ -- Recently, Risen Energy achieved a…
A Look at the Highlights from Phase 1 of the 139th Canton Fair
GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- Focusing on Advanced Manufacturing, Phase 1…
Breaking the Bottleneck in Medical Imaging Core Components: VITAL MedTech Unveils Its Vertical Integration Solution from Materials to Medical Systems at CMEF 2026
SHANGHAI, April 13, 2026 /PRNewswire/ -- At CMEF 2026, VITAL MedTech, the…
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent…
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
April 10, 2026 17:02 ET | Source: Replimune, Inc. WOBURN, Mass., April…
